The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: A possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart

Journal of Molecular and Cellular Cardiology

Volumn 39, Issue 3, 2005, Pages 545-551

  Weiss, T W ^a,c   Kvakan, H ^a,c   Kaun, C ^a,c   Zorn, G ^a,c   Speidl, W S ^a,c   Pfaffenberger, S ^a,c   Maurer, G ^a,c   Huber, K ^b   Wojta, J ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

^c Ludwig Boltzmann Cluster for Cardiovascular Research   (Austria)

Author keywords

Cardiac fibroblasts; Cardiac myocytes; Gp130; MMP; OSM; TIMP

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CARDIOTROPHIN 1; GELATINASE A; GELATINASE B; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; ONCOSTATIN M; SD 202190; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; UROKINASE;

ADULT; ARTICLE; CELL TYPE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STABILITY; UPREGULATION;

CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GENE EXPRESSION REGULATION; GROWTH INHIBITORS; HEART VENTRICLES; HUMANS; MYOCYTES, CARDIAC; ONCOSTATIN M; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

TRIXIS;

EID: 23644462114     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.03.015     Document Type: Article

References (30)

1. E.E. Creemers, J.P. Cleutjens, J.F. Smits, and M.J. Daemen Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ. Res. 89 3 2001 201 210
2. M.P. Vincenti, L.A. White, D.J. Schroen, U. Benbow, and C.E. Brinckerhoff Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability Crit. Rev. Eukaryot. Gene Exp. 6 4 1996 391 411
3. C.M. Dollery, J.R. McEwan, and A.M. Henney Matrix metalloproteinases and cardiovascular disease Circ. Res. 77 5 1995 863 868
4. J.P. Cleutjens, J.C. Kandala, E. Guarda, R.V. Guntaka, and K.T. Weber Regulation of collagen degradation in the rat myocardium after infarction J. Mol. Cell. Cardiol. 27 6 1995 1281 1292
5. M.L. Coker, M.A. Doscher, C.V. Thomas, Z.S. Galis, and F.G. Spinale Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations Am. J. Physiol. 277 2 Pt 2 1999 H777 H787
6. S.C. Tyagi, S.G. Kumar, J. Banks, and W. Fortson Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium J. Mol. Cell. Cardiol. 27 10 1995 2177 2189
7. E.E. Creemers, J.N. Davis, and A.M. Parkhurst Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice Am. J. Physiol. Heart Circ. Physiol. 284 1 2003 H364 H371
8. S. Heymans, A. Luttun, and D. Nuyens Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure Nat. Med. 5 10 1999 1135 1142
9. K. Macfelda, T.W. Weiss, and C. Kaun Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes J. Mol. Cell. Cardiol. 34 12 2002 1681 1691
10. K. Kunisada, H. Hirota, and Y. Fujio Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes Circulation 94 10 1996 2626 2632
11. H. Oh, Y. Fujio, and K. Kunisada Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes J. Biol. Chem. 273 16 1998 9703 9710
12. L. Tong, D. Smyth, C. Kerr, J. Catterall, and C.D. Richards Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts Cell. Signal. 16 10 2004 1123 1132
13. J. D'Armiento Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction Trends Cardiovasc. Med. 12 3 2002 97 101
14. J. Diez Emerging role of matrix metalloproteinases in the pathophysiology of cardiac diseases Eur. J. Clin. Invest. 32 5 2002 291 294
15. Y.Y. Li, C.F. McTiernan, and A.M. Feldman Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling Cardiovasc. Res. 46 2 2000 214 224
16. A.M. Romanic, C.L. Burns-Kurtis, B. Gout, I. Berrebi-Bertrand, and E.H. Ohlstein Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit Life Sci. 68 7 2001 799 814
17. Z.Y. Tao, M.A. Cavasin, F. Yang, Y.H. Liu, and X.P. Yang Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice Life Sci. 74 12 2004 1561 1572
18. L.E. Rohde, A. Ducharme, and L.H. Arroyo Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice Circulation 99 23 1999 3063 3070
19. Y.Y. Li, A.M. Feldman, Y. Sun, and C.F. McTiernan Differential expression of tissue inhibitors of metalloproteinases in the failing human heart Circulation 98 17 1998 1728 1734
20. S.C. Tyagi, S.G. Kumar, and S.J. Haas Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy J. Mol. Cell. Cardiol. 28 7 1996 1415 1428
21. F.G. Spinale, M.L. Coker, and L.J. Heung A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure Circulation 102 16 2000 1944 1949
22. Y.Y. Li, C.F. McTiernan, and A.M. Feldman Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells Cardiovasc. Res. 42 1 1999 162 172
23. D.A. Siwik, D.L. Chang, and W.S. Colucci Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro Circ. Res. 86 12 2000 1259 1265
24. A. Sigel, J.A. Douglas, and M. Eghbali-Webb Regulation of mRNA transcripts and DNA synthesis in the rat heart following intravenous injection of transforming growth factor beta 1 Mol. Cell. Biochem. 141 2 1994 145 151
25. U. Seeland, C. Haeuseler, and R. Hinrichs Myocardial fibrosis in transforming growth factor-beta (1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase Eur. J. Clin. Invest. 32 5 2002 295 303
26. M.J. Gomez-Lechon Oncostatin M: signal transduction and biological activity Life Sci. 65 20 1999 2019 2030
27. G. Florholmen, K.B. Andersson, A. Yndestad, B. Austbo, U.L. Henriksen, and G. Christensen Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism Acta Physiol. Scand. 180 2 2004 133 142
28. T.W. Weiss, W.S. Speidl, and C. Kaun Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes Cardiovasc. Res. 59 3 2003 628 638
29. N. Sohara, M. Trojanowska, and A. Reuben Oncostatin M stimulates tissue inhibitor of metalloproteinase-1 via a MEK-sensitive mechanism in human myofibroblasts J. Hepatol. 36 2 2002 191 199
30. T. Aoyama, Y. Takimoto, and D. Pennica Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat J. Mol. Cell. Cardiol. 32 10 2000 1821 1830